Wed Oct 06 2021
In our latest webinar we discuss the future of clinical trials. John Zibert, CEO of Studies&Me talks about how his company conducts decentralized, virtual clinical trials. Our own Justin Cope then presents the technology behind biotx.ai, which is able to discover drug targets with a high likelihood of success in clinical trials.